Social Programme

As always, BioTrinity has a vibrant social programme and an ideal opportunity for informal networking. For 2014, all social events are open to all delegates - however remember to pre-book and reserve your place at registration. 

Monday12th May, 2014 - BioTrinity 2014 - Novotel West London
18:30-20:30
The BioTrinity Welcome Reception will take place at the conference venue.  Further details will be announced in due course.  It is free to registered delegates, but please ensure you register to reserve your place at this popular pre-conference event.
18:30-23:00
Investor-only Dinner is an invitation-only dinner that will give investors the chance to get together in an exclusive environment.  Available only to investors active in the Life Science sector who will receive an exclusive invitation and registration for BioTrinity 2014 is part of the invitation acceptance.

 

Tuesday 13th May 2014 - BioTrinity 2014 - Novotel West London
17:30-18:30
Connect for Drinks Reception will take place in the heart of the Exhibition at Novotel West London. A chance to network with delegates over a glass of wine, while discussing the day’s panels and company showcase presentations. Free to registered delegates.

18:30-20:30
The Big London Networking Party Join us for the main social get-together of the conference with drinks and buffet-style food.  This event is free to all registered delegates.  Please ensure you register to reserve your place at this popular networking opportunity.

Wednesday 14th May 2014 - BioTrinity 2014 - Novotel West London
15:50-16:30
Closing Drinks Reception Join fellow delegates for a final drink and celebrate the end of another excellent BioTrinity Conference. Take the chance to network for the final time with business colleagues and make some last minute contacts in the Connect for Growth Zone. Free for all registered delegates to attend.





BioTrinity 2013 highlights
877 delegates from 28 countries
520 companies
168 speakers
86 company presentations
1679 scheduled one-to-one meetings
97 investors from 11 countries
66 exhibitors
32 global pharma/corporate venture